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The effects of venoarterial extracorporeal membrane oxygenation on left 
ventricular performance have not been studied in detail. Coronary arterial flow 
obtained by direct measurement with an electromagnetic flowmeter and blood 
gas analysis from the aortic root were tabulated uring venoarterial extracor- 
poreal membrane oxygenation in 14 puppies, and these parameters were 
evaluated with respect o changes in the venoarterial extracorporeal mem- 
brane oxygenation flow. Unique automatic blood pumps generating pulsatile 
flow were used for the venoarterial extracorporeal membrane oxygenation 
bypass. Coronary arterial flow decreased as the extracorporeal membrane 
oxygenation flow increased (106 - 26 ml/min per 100 gm of left ventricle at 20 
ml • min -1 • kg bypass flow to 71 - 17 ml/min per 100 gm of left ventricle at 
100 ml • min - l  • kg bypass flow, p < 0.01). There were no significant changes 
in the mean or diastolic pressures in the ascending aorta despite changes in 
the extrac0rporeal membrane oxygenation flow. Arterial oxygen tension in the 
ascending aorta was not increased even under high-flow venoarterial extracor- 
poreal membrane oxygenation. This result indicates that oxygenated blood 
from the extracorporeal membrane oxygenation circuit does not pass in a 
retrograde fashion into the aortic root and thus does not perfuse the coronary 
arteries. The diastolic aortic pressure did not correlate with the changes in 
extracorporeal membrane oxygenation flow. The decrease in coronary arterial 
flow is therefore predominantly caused by increased coronary arterial resis- 
tance. Tension-time index, an indicator of myocardial oxygen consumption, did 
not decrease with venoarterial extracorporeal membrane oxygenation. In 
conclusion, high-flow venoarterial extracorporeal membrane oxygenation 
causes undesirable hemodynamic effects on the left ventricle. (J TtIORAC 
CARDIOVASC SURG 1996;1!1:630-6) 
V enoarterial extracorporeal membrane oxygen- ation (VA-ECMO) is a widely accepted life- 
support measure for neonates with life-threatening 
respiratory failure. Although its obvious benefit for 
respiratory function cannot be denied, the effects of 
VA-ECMO on left ventricular performance have 
not been delineated. In previous experimental stud- 
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ies, we showed that the LVEDP increases and 
cardiac output decreases as the extracorporeal 
membrane oxygenation (ECMO) flow increases 
during VA-ECMO.  1 These findings are indicative of 
the possible undesirable effects of VA-ECMO on 
left ventricular function. 
The purpose of this study was to determine the 
effects of VA-ECMO on coronary arterial flow 
(CAF) by means of direct measurement with an 
electromagnetic flowmeter. In addition, the ques- 
tion of whether the left ventricle was perfused 
directly by retrograde flow in the ascending aorta 
from the ECMO circuit was investigated by analyz- 
ing oxygen tension in the aortic root. 
Materials and methods 
Devices and driving systems. The ECMO circuit con- 
sists of a self-regulating blood pump (the Takagi pump 2) 
and a silicone hollow-fiber membrane oxygenator with a 
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Fig. 1. Schematic diagram of the VA-ECMO circuit and experimental model. Note the placement of the 
electromagnetic flow probe on the coronary artery and the cannulation sites for hemodynamic measure- 
ments. 
surface area of 0.5 m 2 (MERASILOX-S; Senkoh Ika 
Kogyo Inc., Tokyo, Japan). A pair of sack-type pumps are 
driven in alternation by compressed air under automatic 
control. The ECMO flow, which is monitored with an 
electromagnetic flowmeter, is automatically regulated by 
changes in pumping rates and driving air pressure of the 
pump in response to hemodynamic hanges of the 
body.~, 3, 4 Because venous blood drains only by gravity 
and the pump does not generate as much excessive 
negative pressure as a roller pump does, no venous 
reservoir is necessary and the total priming volume of the 
ECMO circuit is only 65 ml. Our sack-type pump pro- 
duces pulsatile flow; it has been used for purposes of 
automatic regulation of the ECMO flow, however, not for 
the pulsatile flow. Moreover, the membrane oxygenator 
has a large pressure resistance and the pulse pressure 
generated by the pump is reduced to 20% through the 
membrane oxygenator. 1 The flow at the arterial site of the 
circuit thus resembles continuous flow produced by a 
roller pump, so the pumping of our ECMO circuit may 
not be synchronized with the natural beating heart. 
Materials. Fourteen small mongrel dogs with a mean 
weight of 3.5 kg (range 2.6 to 5.0 kg) were studied. All 
experiments were performed in accordance with the "An- 
imal Experimental Guide--Nagoya University School of 
Medicine" (Nagoya University, revised in 1989). The 
animals received humane care in compliance with the 
"Principles of Laboratory Animal Care" formulated by 
the National Society for Medical Research and the 
"Guide for the Care and Use of Laboratory Animals" 
prepared by the Institute of Laboratory Animal Resources 
and published by the National Institutes of Health (NIH 
Publication No. 86-23, revised 1985). 
Methods. The animals were anesthetized with thiamy- 
lal sodium (10 mg/kg). They were then intubated, venti- 
lated, and subjected to general endotracheal nesthesia 
with continuous intravenous ketamine chloride (10 mg/kg 
per hour) and pancuronium bromide (0.1 mg/kg per 
hour). Blood products were not administered during the 
study except for priming of the ECMO circuit with fresh 
blood. Ventilator settings were reduced to achieve respi- 
ratory rates of 10 breaths/min and peak inspiratory pres- 
sures of 10 cm H20 with room air before the start of 
VA-ECMO, and these settings were maintained uring 
VA-ECMO. 
An inflow catheter was inserted into the right atrium 
through the right external jugular vein (Fig. 1). An outflow 
catheter was inserted into the common carotid artery. The 
mediastinum was entered through a median sternotomy 
and the heart was suspended in the pericardial cradle. A 
22-gauge catheter was inserted into a branch of the left 
femoral artery to measure the femoral arterial systemic 
pressure (FAP). A 5F polyethylene catheter was passed 
through the right femoral artery with its tip positioned just 
above the sinus of Valsalva for measurement of the 
ascending aortic pressure (AoP) and procurement of 
blood samples. Left ventricular pressure (LVP) was mon- 
itored with a 3F transauricular catheter. A continuous 
electrocardiogram was recorded. The hemodynamic pa- 
rameters were monitored with pressure transducers 
(P23ID; Gould, Inc., Oxnard, Calif.) and recorded on a 
multichannel polygraph (Polygraph 363; NEC-Sanei Inc., 
Tokyo, Japan). Blood samples were drawn from the left 
ventricle, ascending aorta, and femoral artery for blood 
gas determination with a gas analyzer (NOVA SP5; NOVA 
Biomedical Corporation, Waltham, Mass.). The tension- 
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Table I. Hernodynamic parameters before and during VA-ECMO 
VA-ECMO f low (rnl • rain 1 . kg 1) 
0 20 40 60 80 100 
CAF (ml/min per 100 gm LV) 135 ± 46 106 + 26 96 _+ 20 89 + 22 77 ± 18 71 _+ 17" 
Systolic LVP (ram Hg) 125 ± 41 111 _+ 33 107 + 35 102 ± 37 94 ± 35 93 _+ 30* 
AoP (mm Hg) 
Systolic 100 ± 23 85 -+ 11 84 ± 15 80 -+ 17 78 _+ 19 78 _+ 20 
Diastolic 72 _+ 6 53 ± 14 56 _+ 14 56 ± 16 56 +_ 18 56 + 21 
Mean 84 ± 24 66 ± 14 68 -- 14 66 ± 17 66 ± 18 65 + 21 
Mean FAP (ram Hg) 83 ± 29 64 +_ 14 66 -- 14 64 +_ 17 63 ± 19 63 ± 21 
TTI (%) 100 93 + 18 102 ± 24 99 ± 22 99 _+ 24 102 _+ 35 
Data mean -- standard eviation; n = 14. LV, Left ventricle. 
*Statistical significance compared with value at flow rate of 20 ml. min-i . kg-a (p < 0.01). 
time index (TTI) was computed from data obtained through 
planimetry of the systolic phase by means of the LVP 
tracings. TFI was determined by calculation of the area 
beneath the systolic portion of the LVP curve tracings: ,6 
CAF was measured with an electromagnetic flowmeter 
(FJ-015T; Nihon Kohden Inc., Tokyo, Japan). A flow 
probe was placed on the left anterior descending coronary 
artery. Because 45% of the total coronary blood flow is 
distributed to the left anterior descending arteryl 7 the 
total CAF was estimated from the measured CAF on the 
left anterior descending artery and expressed per 100 gm 
wet weight of the left ventricle. Coronary vascular esis- 
tance was calculated by dividing mean AoP by total CAF. 
After VA-ECMO was initiated between the right 
atrium and the right common carotid artery, the flow was 
increased in 20 ml • rain -1 • kg -1 increments to a maxi- 
mum bypass flow of 100 ml • min -1 • kg -1. In nine of the 
14 animals, the flow was then decreased in 20 ml. 
rain -1 .kg 1 increments to 'a bypass flow of zero. All 
measurements were made after a 5-minute stabilization 
period at each flow rate. 
Statistical analysis. Results are expressed as mean 2 
standard eviation. Analysis of variance and the paired 
t test were used to analyze the data. Differences were 
considered statistically significant at a p value less than 
0.05. 
Results 
CAF. CAF increased significantly with reduced 
ventilator settings and decreased significantly 
shortly after the initiation of ECMO (Table I). CAF  
continued to fall with increases in the ECMO flow 
(Fig. 2). As the ECMO flow was decreased from the 
maximum of 100 ml .  rain -1 .  kg -1 to 20 ml .  
min -~-  kg -1, CAF  increased and eventually re- 
turned to baseline. CAF was thus inversely propor- 
tional to the ECMO flow. 
LVP, AoP, and FAP. LVP decreased when the 
ECMO flow was increased to greater than 80 ml • 
rain -1 .  kg -1 (Table I). The systolic AoP also de- 
creased gradually after the initiation of ECMO.  
After a rapid fall shortly after the initiation of 
ECMO,  the diastolic and mean AoPs remained low. 
The mean FAP exhibited a pattern of changes 
similar to those in the mean AoP. None of these 
changes, however, were statistically significant. 
Blood gas analyses. Low pre-ECMO arterial ox- 
ygen tension (Pao2) in the left ventricle, ascending 
aorta, and femoral artery resulted from reduced 
venti lator settings. As the ECMO flow was in- 
creased to greater than 60 ml • rain -1 • kg -1, Pao 2 
in the femoral  artery increased significantly (76 +_ 
29 mm Hg before ECMO to 174 2 80 mm Hg at 
60 ml .  rain - l ' kg  -1, p < 0.01; Fig. 3). On the 
other hand, Pao 2 in the left ventricle and ascend- 
ing aorta did not change significantly. The dispar- 
ity in Pao 2 at the different sites became more 
prominent  as the ECMO flow was increased to 
100 ml - ra in  t .  kg -1. The difference in Pao 2 
between the left ventricle and ascending aorta was 
not significant. The ascending aorta was thus 
perfused by blood that had been ejected by the 
left ventricle. There were no significant changes in 
arterial carbon dioxide tension at the different 
ECMO flow rates or at the different sites. 
TTI. TTI  at a bypass flow of 20 ml • min -1 • kg -1 
was 7% less than the level before ECMO;  how- 
ever, TTI  was not significantly different from base- 
line with ECMO flow rates greater than 40 ml. 
rain-1, kg 1 (Table I). Myocardial oxygen consumption 
is thus not reduced espite the bypassing of blood from 
the heart with the VA-ECMO circuit. 
Coronary vascular resistance. Coronary vascular 
resistance at a bypass flow of 20 ml • rain -1 • kg -1 
was 20 mm Hg.  ml -~ .  rain -1 per 100 gm left 
ventricle less than the level before VA-ECMO.  
Coronary vascular esistance rose significantly, how- 
ever, with an increase in bypass flow (Fig. 4). 
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Fig. 2. CAF as a function of bypass flow. Ventilation settings were reduced to 10 cm 1-120 peak inspiratory 
pressure and 10 breaths/rain respiratory ate between period before VA-ECMO (pre) and the initiation of 
VA-ECMO. CAF increased significantly with reduced ventilator settings and decreased significantly shortly 
after the initiation of ECMO. CAF continued to fall with increases in the ECMO flow. As the ECMO flow 
was decreased from the maximum of 100 ml • min -1 • kg 1 to 20 ml • min -1 • kg -1, CAF increased to the 
same level as before VA-ECMO. gLV,, Grams of left ventricle, wet weight; SD, standard eviation. 
Discuss ion  
The effect of VA-ECMO on cardiac performance 
may play a significant role in determining outcome 
in critically ill children. Unfortunately, this impor- 
tant issue has not previously been studied in detail. 
In particular, myocardial oxygen consumption and 
CAF during VA-ECMO have not been delineated. 
Only recently has the regional blood flow to the 
heart during ECMO been discussed on the basis of 
studies with isotope-labeled microspheres sl° or 
Doppler ultrasonography, tl This study is the first to 
determine CAF during VA-ECMO, as directly mea- 
sured by an electromagnetic flowmeter. The obser- 
vation that coronary perfusion is significantly re- 
duced during VA-ECMO is in agreement with 
conclusions from previous studies with the radiola- 
beled microsphere technique, s' 9 Smith and associ- 
ates studied the relative blood flow of the various 
organs in lambs by counting isotope-labeled albu- 
min injected from the perfusion cannula and con- 
cluded that the relative coronary blood flow from 
the cannula was significantly less than that in the 
control group. Nowlen and coworkers 9 used a simi- 
lar isotope method in rabbits during ECMO; they 
injected the isotope from the ventricle and the 
perfusion cannula. Their data suggest that perfusion 
of the heart is significantly reduced uring low-flow 
ECMO. These two interesting studies did not eval- 
uate the relationship between the ECMO flow rate 
and CAF. 
Coronary blood flow is regulated by a variety of 
factors, including perfusion p:essure of the coronary 
artery, myocardial oxygen demand, coronary arterial 
resistance, lasticity of the aortic bulb, and autoreg- 
ulation, t2 The coronary perfusion pressure depends 
on the pressure both in the aortic root and at the 
coronary sinus. Because the progressive decrease in 
CAF during ECMO was not accompanied by any 
significant decrease in the aortic root pressure, it 
seems unlikely that a decrease in the perfusion 
pressure was the cause of the drop in CAF. When 
the heart is bypassed with VA-ECMO or left heart 
bypass, there should be a lower myocardial oxygen 
demand. This would result in a compensatory de- 
crease in CAF. Early studies of the left ventricular 
assist device revealed no significant changes in cot -  
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Fig. 3. Blood gas analysis during VA-ECMO. Pao 2 and arterial carbon dioxide tension (Pac02) were measured in blood 
obtained from the femoral artery (FA), ascending aorta (Ao), and left ventricle (LV). A low Pa02 before ECMO (pre) in 
the FA resulted from reduced ventilator settings. Pao z in the FA increased significantly with ECMO flows greater than 60 
ml • min -~ • kg 1. There were no significant changes in Pa02 in the LV or Ao. The disparity in Pa02 among the different 
sites became more prominent as the ECMO flow was increased to 100 ml • min -1 • kg -i. There were no significant 
changes in Paco 2 at the different ECMO flow rates or at the different sites. 
onary blood flow or myocardial oxygen consump- 
tion. 1315 On the contrary, others have reported 
decreases in coronary flow and significant reduc- 
tions in myocardial oxygen consumption. 5' 16 With 
implementation of ECMO, we noted no significant 
change in TTI, which has been used as an indicator 
of myocardial oxygen consumption. 6 The observed 
decrease in CAF cannot be explained by a decrease 
in myocardial oxygen demand. 
Coronary vascular resistance increased as the 
ECMO flow increased (Fig. 4). Increased extravas- 
cular resistance caused by elevated myocardial tis- 
sue pressure may account for the increased coronary 
vascular esistance during high-flow VA-ECMO. A 
Doppler echocardiographic study of neonates un- 
dertaken by Martin and colleagues 17 revealed that 
left ventricular end-systolic wall stress increases 
during VA-ECMO. The increase in left ventricular 
wall stress could be responsible for the increase in 
coronary vascular esistance during VA-ECMO. Ba- 
varia and coworkers i have studied the effects of 
ECMO on the normal and ischemic heart in sheep 
by using ultrasonic crystals to measure changes in 
left ventricular wall thickness and left ventricular 
volume. They showed that as ECMO flow increased 
the end-diastolic volume decreased. In addition, 
ECMO produced small decreases in ventricular 
volume in normal hearts. Such small decreases 
resulted in no changes in the LVP. In previous 
studies, we have shown an increase in LVEDP 
during high-flow ECMO and have speculated that 
this could result in an increase in coronary vascular 
resistance and consequent decrease in coronary 
flow) 
The expanded aorta acts as a reservoir for the 
delivery of blood to the heart during diastole, when 
the coronary arteries are perfused. Absence or 
minimization of pulsation during VA-ECMO may 
lead to incompetent reservoir function of the aortic 
root. Such impaired reservoir function of the ex- 
panded aorta, caused partially by the decrease in 
cardiac output, may also contribute to the decrease 
in CAF. According to Grattan and associates, i9 who 
conducted Doppler echocardiographic studies in 
infants placed on ECMO, cardiopulmonary bypass 
abolishes the normal autoregulation of coronary 
flow and can result in "coronary steal syndrome." 
Kjekshus, 2° who observed the loss of autoregulation 
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Fig. 4. Coronary resistance as a function of bypass flow. The coronary resistance decreased with reduced 
ventilator settings and increased with increases in bypass flow. The difference in coronary resistance 
between the peak ECMO flow (100 ml • min 1. kg-i) and minimal ECMO flow (20 ml • rain i .  kg-1) 
was statistically significant (p < 0.01). The coronary resistance r turned to baseline as the bypass flow was 
decreased, gLV, Grams of left ventricle, wet weight; SD, standard eviation. 
of the coronary flow with increases in LVEDP, 
reported that the increased ventricular filling pres- 
sure can impede coronary flow during diastole in the 
ischemic heart. The significance of these effects on 
CAF during VA-ECMO could not be discerned. 
The lack of an obvious increase in Pao 2 in the 
ascending aorta with high-flow VA-ECMO indicates 
that the coronary arteries were perfused mainly with 
blood ejected from the left ventricle. There was no 
evidence of direct retrograde flow of the well-oxygen- 
ated blood to the coronary arteries from the VA- 
ECMO circuit. In addition, cardiac output is de- 
creased in inverse proportion to the ECMO flow. l' 8, 9 
In a Doppler ultrasonographic study of neonates, 
Walther and colleagues il reported that a significant 
decrease in the left and right ventricular output is 
proportional to the amount of bypass flow provided as 
well as to the decrease in left ventricular contractility. 
A marked decrease in cardiac performance r ported 
in some infants placed on ECMO has been termed 
"cardiac stun syndrome. ''21 It is likely that the heart 
does not receive an adequate supply of oxygen because 
of the reduced CAF and lack of direct supply of 
oxygenated blood from the VA-ECMO circuit. 
Asynchronous flow and a pulse pressure gener- 
ated by an extracorporeal circuit may also impede 
pulsatile aortic blood flow during high-flow VA- 
ECMO. The pulse pressure generated by our pump, 
however, is reduced to 20% through the membrane 
oxygenator. 1 Pulsatile flow of this magnitude with- 
out synchronization i  our ECMO circuit does not 
appear to exert much influence on the function of 
the natural beating heart. 
In conclusion, CAF decreases as VA-ECMO flow 
increases. In addition, oxygenated blood from the 
ECMO circuit does not pass in a retrograde fashion 
from the ascending aorta to the coronary arteries. 
Coronary perfusion is thus derived only from blood 
ejected by the left ventricle. High-flow VA-ECMO 
therefore exerts undesirable hemodynamic effects 
on the left ventricle. Similar findings would presum- 
ably apply to cardiopulmonary bypass for cardiac 
operations, pecifically when bypass is initiated and, 
more important, when the patient is weaned from 
bypass to spontaneous cardiac support. In our study, 
we used the canine model with intact cardiac func- 
tion. Further study is needed to assess left ventric- 
ular performance and CAF in an experimental 
model with a left ventricle compromised by ischemic 
insult or high-dose/3 blockade. 
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